Navigation Links
Bill Gates to Fund £28m for Malaria researc

Bill Gates is to fund £28m for research in United Kingdom as part of £145m package for research programs worldwide for the eradication of Malaria worldwide. Bill Gates along with his Melinda Gates Foundation is going to sponsor three // international projects for malaria eradication over the next five years. Mr. Gates expressed that more research funding is contributed to research of AIDS and cancer, while malaria, which kills millions of children worldwide, has become a forgotten epidemic. He is confident that if we could expand malaria control programs, and invest what's needed in research and development, we can stop this tragedy.

Liverpool School Project:

Liverpool's Innovative Vector Control Consortium (IVCC) Project is granted to the Liverpool School of Tropical Medicine that will be funded to work on projects that will look at ways to control the mosquitoes that spread malaria by developing safer, more effective, and longer-lasting insecticides for mosquito control. It will also develop improved bed nets and other insecticide-treated materials, and help health authorities determine how to deploy insecticides and bed nets for maximum impact.

Malaria Vaccine Initiative (MVI) Project:

The MVI project will receive a grant of £60.4m for conducting clinical trial of newly developed Malarial vaccine by GlaxoSmithKline in Mozambique, Africa. The newly developed vaccine is found to protect young children’s from Malaria infection. The vaccine gives protection in 58% of children’s. The grant will help in doing further clinical trials in 10,000 children and check that the vaccine is safe when given with other childhood vaccines, it can be introduced into Africa's immunisation programme by around 2011.

Medicines for Malaria Venture (MMV) Project:

Medicines for Malaria Venture (MMV) will be receiving a grant £56.1m for developing new malaria drugs. The project would aim at producing a ffordable and more effective drugs that can be used in economically poor countries. The project aims at developing new compounds, which are effective against malarial parasites, and organizing clinical trials of the new compounds. The researchers feel that due to increased resistance shown to drugs such as Chloroquine by the parasites there is a increased need for identifying new drug compounds. The organizers are confident that they could produce new effective drugs that cost $1 or less per person treated.

Experts View:

Experts from Malaria R&D Alliance, an international group of malaria organizations, says that more funding is still needed to rapidly expand access to existing malaria control strategies such as bed nets, mosquito control, and combination drug treatment. The International group has urged that more than $3.2 billion is needed every year for research in Malaria eradication.

Spokeswoman of Roll Back Malaria Partnership Secretariat said, “The new funding from the Gates' would make a big difference and we absolutely have to have more funds for research. As quickly as we can develop new drugs we also have drug resistance." She said funding should also be given to operational research to make sure that communities affected by malaria know how best to protect themselves against the disease.

Source: BBC ews.
'"/>




Related medicine news :

1. Bill Gates Takes Personal Interest in AIDS Program
2. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
3. Gates Foundation to donate USD 104 million to TB Alliance
4. Bill Gates Clarifies that his Decision to Focus on Charity was Personal
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Gates Foundation Adopts Fight against Encephalitis
7. Clinton, Gates Highlight Treatment, Discrimination of AIDS
8. $68 million aid pours in from Gates Foundation to fight tropical diseases
9. Gates Foundation Grants $23mn for AIDS programme in India
10. Bill Gates pours in funds for diarrhea treatment reseach
11. Gates Foundation Pledges $3 Million to Fight Malaria in Africa
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/29/2017)... ... ... The quest to develop a cure for HIV has long been plagued by ... has a knack for lying dormant in immune cells at levels undetectable to all ... Graduate School of Public Health announced today in Nature Medicine that they’ve created a ...
(Date:5/28/2017)... Melbourne, FL (PRWEB) , ... May 28, 2017 ... ... Partners of America (PPOA), is proud to announce that Jorge Fernandez-Silva, M.D., has ... comprehensive interventional pain management, a specialty that concentrates on minimally invasive techniques to ...
(Date:5/27/2017)... ... May 26, 2017 , ... A May 8 article ... for colds or respiratory issues that are not responsive to antibiotics nevertheless obtain prescriptions ... may be largely responsible for the problem both in Canada and the United States. ...
(Date:5/27/2017)... ... May 27, 2017 , ... From May 21-23, hearing healthcare professionals ... event was held at the Marriott Syracuse Downtown Hotel in Syracuse, New York. ... network of independent hearing healthcare providers to help them stay ahead in the industry. ...
(Date:5/26/2017)... ... May 26, 2017 , ... The American Parkinson Disease Association’s ... eighty-nine grant submissions all vying for nearly $1,000,000 in funding that will be ... The American Parkinson Disease Association (APDA) is focused on advancing scientific research that ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... , May 23, 2017  Leaf Healthcare, ... innovative medical devices for pressure ulcer prevention, will ... American Association of Critical Care Nurses, National Teaching ... 22-25. The Leaf Patient Monitoring System ... for the hospital environment.  The system seamlessly tracks ...
(Date:5/18/2017)... 18, 2017  Two Bayer U.S. Pharmaceutical leaders received ... its recent 28 th Woman of the ... showcases HBA,s longstanding mission of furthering the advancement and ... Cindy Powell-Steffen , senior director of brand ... and Libby Howe , a regional business manager ...
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
Breaking Medicine Technology: